Options Lab PDF Oscar Pico-Espinosa receives award

Oscar’s research on Reasons for declining PrEP, part of the PRIMP project, received a Trainee Award and will be presented at the major infectious diseases conference ID Week at the end of September 2021.  Congratulations Oscar!  See the conference webpage here.

Read more
Options Lab receives federal funding for COVID-19 prevention trial, ranking 2nd out of 438 in competition

As of June 25, 2020, the Options Lab received federal funding for a COVID-19 clinical trial which aims to investigate if a 14 day course of oral Kaletra (lopinavir/ritonavir), which is currently used as one strategy for HIV post-exposure prophylaxis (PEP), is effective as COVID-19 PEP. More information can be found here.

Read more